Projects

Schott’s Glass Tubing Production Facility

German specialty glass and glass-ceramics manufacturer and supplier Schott is building a pharmaceutical glass tubing production facility in Jinyun, China. 

Project Type

Glass tubing production plant

Location

Jinyun, China

Start of Construction

August 2019

Expected Completion

2020

Expand

German specialty glass and glass-ceramics manufacturer and supplier Schott is building a pharmaceutical glass tubing production facility in Jinyun, China.

Plans were announced in October 2018 while the ground-breaking ceremony was held in August 2019.

The plant is being developed to meet the increasing demand for Type 1 pharmaceutical tubing in China. It will create 300 new jobs and is expected to be completed by late 2020.

The project is a part of the company’s current expansion plans and is being developed alongside a melting tank in India and a new production facility in Switzerland.

Schott’s glass tubing production facility location

The new pharmaceutical glass tubing production facility will be located in Jinyun County in the Zhejiang Province of China.

Schott has operated an existing Jinyun manufacturing site for 25 years. The site serves more than 200 customers and provides premium customer service.

Schott’s glass tubing production facility details

Schott’s new pharmaceutical glass tubing production plant spans 113,000m² and will manufacture Fiolax® glass tubing, which is a 5.0 middle borosilicate glass.

The facility will be equipped with the company’s most advanced production technology, consistent with its other global sites. Schott will invest €60m ($69.8m) in the facility’s first operational phase to achieve an annual production capacity of up to 20,000t.

The manufacturing process will use Schott’s perfeXionquality processing technology, which will adhere to the company’s global quality criteria and incorporate complete quality control for each individual tube.

Details of Fiolax glass tubing

Developed in 1911, the Fiolax Type I glass tube complies with all international pharmaceutical regulations. It is neutral, with low alkali and high hydrolytic contents making it resistant to chemicals.

The Fiolax glass tubes can be developed into various pharmaceutical containers such as flasks, syringes and ampoules. They are manufactured using an optoelectric measuring system, which monitors the production of each tube to ensure high-quality products.

“The plant is being developed to meet the increasing demand for Type 1 pharmaceutical tubing in China.”

The glass tubing preserves the efficacy of medicine while its high hydrolytic resistance decreases contamination risks, leading to minimal packaging requirements.

Fiolax’s amber variant effectively protects contents against UV radiation and short-wave visible light.

The tubes also offer optional glass-tube coating for protection against scratches, customised cutting of tube ends and packaging protection through Densopack® technology.

Details of Schott’s perfeXion technology

Schott’s perfeXion is a quality control technology used for transitioning each Fiolax tube from statistical quality control to complete inspection. The quality specifications of the original tube are conformed into the desired container shape using online inspection devices and integrated data analysis.

The technology facilitates consistent wall thickness in the initial tube, enabling a definite hot-forming process in various sections of the container. The process provides tightly defined inner diameters of the original tube, which safeguards constant gliding force with an improved dosing accuracy.

The complete inspection of each glass tube results in reduced yield loss during primary packaging. PerfeXion was among the top 15 innovations at the Medicine Maker Innovation Awards in 2016.

Marketing commentary on Schott

In 1884, Schott was founded by Otto Schott, Ernst Abbe and Carl Zeiss in Jena, Germany. Its parent company, Schott AG, is headquartered in Mainz, Germany, and is owned by the Carl Zeiss Foundation.

Schott serves several industries, including pharmaceuticals, automotive, electronics, life sciences and aviation. It has more than 15,500 employees at various sites and sales offices across 33 countries, with 5,550 located in Germany.

More than 86% of the company’s global sales are generated outside of Germany, with 46% from Europe, 24% from Asia, 24% from North America and 5% from South America.

Related Projects